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Introduction {#j_hukin-2016-0055_s_001}
============

Athletic performance and response to exercise training are determined by various exoand endogenous factors ([@j_hukin-2016-0055_ref_019]). Analysis of heritability enabled to discover that body characteristics related to physical performance such as cardiovascular and respiratory variables, e.g., maximal oxygen uptake (VO2max), running velocity at the anaerobic threshold (VAT), cross-sectional surface area of muscles, neuromuscular coordination, as well as cardiovascular and respiratory systems' variables have strong genetic background ([@j_hukin-2016-0055_ref_003]; [@j_hukin-2016-0055_ref_026]; [@j_hukin-2016-0055_ref_034]; [@j_hukin-2016-0055_ref_036]). Rapid development of molecular methods enabling the research of the structure and sequence of the human genome, and the usage of the model based on association analysis of candidate genes in sports has become feasible. To date, nearly 80 molecular markers have been reported to be correlated with physical performance, exercise and fitness as well as trainability ([@j_hukin-2016-0055_ref_001]; [@j_hukin-2016-0055_ref_002]).

One of the candidate genes that have been recently studied in this context is MTHFR. The gene coding for 5,10-methylenetetrahydrofolate reductase (MTHFR) catalyses the irreversible reduction of 5,10-methylenetetrahydrofolate to 5-methyltetrahydrofolate, the primary form of serum folate ([@j_hukin-2016-0055_ref_029]). MTHFR is one of the key enzymes in the metabolism of single-carbon fragments such as purine and pyrimidine synthesis, as well as conversion of homocysteine to methionine, much of which is converted to S-adenosylmethionine (SAM), a universal donor of methyl groups ([@j_hukin-2016-0055_ref_031]). Therefore, MTHFR is, among others, involved in DNA methylation, the process of covalent addition of a methyl group to cytosine within the context of the CpG dinucleotide ([@j_hukin-2016-0055_ref_037]). A large body of evidence has demonstrated that the methylation of the DNA is associated with the regulation of gene expression and it has been found to be involved in inhibition of gene expression ([@j_hukin-2016-0055_ref_021]). Several polymorphic sites have been described within MTHFR, however, two of them i.e., C677T and A1298C, commonly occur and are most thoroughly explored. The C677T polymorphism has been identified by [@j_hukin-2016-0055_ref_016] and results in a cytosine to thymine substitution at nucleotide position 667 (rs1801133). In consequence, a substitution of alanine for valine in the N-terminal catalytic domain of the protein occurs. The C677T TT homozygotes have been shown to have a decreased enzymatic activity as well as significantly elevated plasma homocysteine levels when compared with the C allel carriers, probably due to the termolabile MTHFR protein ([@j_hukin-2016-0055_ref_016]). The 677T allele has been associated with an increased risk of cardiovascular disease and birth defects ([@j_hukin-2016-0055_ref_022]). A second common MTHFR polymorphism is an adenosine to cytosine transversion at nucleotide position 1298 (A1298C, rs1801131) that results in a glutamate to alanine substitution within C-terminal, Sadenosylmethionine (SAM) regulatory domain of the protein ([@j_hukin-2016-0055_ref_040]). It has been observed that individuals with the 1298 CC genotype have approximately 60 percent specific wild-type in vitro MTHFR activity ([@j_hukin-2016-0055_ref_038]). It suggests that both mutant 677T and 1298C alleles of the MTHFR C677T and A1298C polymorphisms influence lower methylentetrahydrofolate reductase enzyme activity ([@j_hukin-2016-0055_ref_040]; [@j_hukin-2016-0055_ref_038]). While the C677T polymorphism has been established as an important genetic determinant of elevated homocysteine ([@j_hukin-2016-0055_ref_016]), the effect of the A1298C polymorphism on plasma concentrations of homocysteine remains controversial. Some studies reported an impact of A1298C on plasma homocysteine, with CC homozygotes exhibiting higher plasma concentration ([@j_hukin-2016-0055_ref_009], [@j_hukin-2016-0055_ref_008]). On the other hand, the study of [@j_hukin-2016-0055_ref_014] did not yield any significant results.

Despite these discrepancies, both MTHFR genetic variants showed effects on DNA methylation status, although the impact was slightly less pronounced for the A1298C polymorphism. The 1298CC MTHFR genotype has been observed to be associated with DNA hypomethylation status ([@j_hukin-2016-0055_ref_009]). In this case, it could be speculated that reduced MTHFR activity that causes an accumulation of homocysteine disrupts the DNA methylation pattern by favouring the synthesis of Sadenosylhomocysteine (SAH), an inhibitor of DNA methyltransferase, and affecting the synthesis of SAM, the methyl group donor in the process of DNA methylation ([@j_hukin-2016-0055_ref_015]; [@j_hukin-2016-0055_ref_039]). There is growing evidence suggesting that physical training may induce changes in the methylation status of crucial genes involved in e.g. muscle function ([@j_hukin-2016-0055_ref_013]). It has been recently demonstrated that DNA hypomethylation has an impact on the exercise-induced adaptation in skeletal muscles ([@j_hukin-2016-0055_ref_006]; [@j_hukin-2016-0055_ref_037]). It was shown that expression of myogenic factors as well as myotube length and diameter increase when induced by the hypomethylation process. Moreover, when a group of elite athletes was investigated for the genetic polymorphism of genes coding for enzymes involved in the one-carbon metabolism, it was found that MTHFR A1298C, methionine synthase (MTR A2756G) and methionine synthase reductase (MTRR A66G) polymorphic sites were significantly associated with elite athlete status ([@j_hukin-2016-0055_ref_037]).

In our previous study, we analyzed whether the functional A1298C polymorphism in the MTHFR gene was associated with athletic status ([@j_hukin-2016-0055_ref_043]). We investigated the distribution of the A1298C variant in 1144 Polish and Russian athletes as well as in 1540 control participants. Significant differences in genotype (CC and AC) and allele (C) distributions among sprint-strength/strength athletes and sedentary controls for each nationality were found. The results of the study suggest that the functional A1298C polymorphism in the MTHFR gene is associated with athletic status in Polish and Russian athletes, and the presence of the C allele seems to be beneficial in sprint-strength and strength athletes.

Considering the aforementioned studies and promising results of our previous analysis, we decided to verify whether the A1298C polymorphism in the MTHFR gene had influence on the aerobic and anaerobic performance as well as body and mass composition in young Polish women. To test this hypothesis, we conducted a genetic association study that aimed to detect a relationship between the A1298C polymorphism and: i) VO2max test variables, ii) Wingate test variables, and iii) body composition measurements. Therefore, we examined the allele and genotype distribution of the MTHFR A1298C polymorphism in a group of Polish women; furthermore, we measured the changes of VO2max test variables, Wingate test variables and body composition measurements before and after the completion of a 12-week training program to verify whether there was an interaction between the genotype and training.

Material and Methods {#j_hukin-2016-0055_s_002}
====================

Ethics Statement {#j_hukin-2016-0055_s_002_s_001}
----------------

All the procedures followed in the study were approved by the Ethics Committee of the Regional Medical Chamber in Szczecin (Approval number 09/KB/IV/2011) and were conducted according to the principles of the World Medical Association Declaration of Helsinki and ethical standards in sport and exercise science research.

Participants {#j_hukin-2016-0055_s_002_s_002}
------------

Two hundred and one Polish Caucasian women aged 21 ± 1 years (range 19--24) met the inclusion criteria and were included in the study. None of these individuals had engaged in regular physical activity in the previous 6 months. They had no history of any metabolic or cardiovascular diseases. Participants were nonsmokers and refrained from taking any medications or supplements known to affect the metabolism. Participants had no muscle imbalances, which could influence their fitness performance ([@j_hukin-2016-0055_ref_035]). Three weeks before the beginning of intervention and during the training period, participants were asked to keep a balanced diet of approximately 2000 kilocalories per day.

Training Protocol {#j_hukin-2016-0055_s_002_s_003}
-----------------

The training period was preceded by a week-long familiarization stage, when the examined women exercised 3 times a week for 30 min, at an intensity of about 50% of their maximal heart rate (HR~max~). After the week-long familiarization stage, proper training started. Each training unit consisted of a warm-up routine (10 min), the main aerobic routine (43 min), and stretching and breathing exercise (7 min). The main aerobic routine was a combination of two alternating styles i.e. low and high impact. A low impact style comprised movements with at least one foot on the floor at all times, whereas a high impact style included running, hopping and jumping with a variety of flight phases ([@j_hukin-2016-0055_ref_011]). A 12-week program of low-high impact aerobics was divided as follows: (i) 3 weeks including 9 training units, 60 min each, at about 50--60% of HR~max~, tempo 135--140 bpm, (ii) 3 weeks comprising 9 training units, 60 min each, at 60--70% of HR~max~, tempo 140--152 bpm, (iii) 3 weeks including 9 training units, 60 min with an intensity of 65−75% of HR~max~, tempo 145--158 bpm, and (iv) 3 weeks comprising 9 training units, 60 min with an intensity of 65%−80% of HR~max~, tempo 145--160 bpm. All 36 training units were administered and supervised by the same instructor.

Body Composition Measurements {#j_hukin-2016-0055_s_002_s_004}
-----------------------------

All participants were measured for selected body mass and body composition variables before and after the completion of a 12-week training period, which had been shown appropriate to observe changes in body composition ([@j_hukin-2016-0055_ref_023]; [@j_hukin-2016-0055_ref_025]). Body mass and body composition were assessed by bioimpedance analysis (body's inherent resistance to the electrical current) with the use of an electronic scale (Tanita TBF 300M). The device analysed body composition based on the differences of the ability to conduct the electrical current by body tissues (different resistance) due to different water content. Body mass and body composition measurements taken with the use of the electronic scale were as follows: total body mass (kg), fat freemass (FFM, kg), fat mass (kg), fat mass percentage (% FM), body mass index (BMI = body mass (kg) × body height (m^2^)^−1^), total body water (TBW, kg).

Aerobic capacity test (VO~2max~) {#j_hukin-2016-0055_s_002_s_005}
--------------------------------

Subjects performed a continuous graded exercise test on an electronically braked cycle ergometer (VIAsprint™ 150P Bicycle, CareFusion Germany GmbH, Hoechberg, Germany) with an automatically calibrated volume sensor and a breath-by-breath gas analyzer (Oxycon Pro, Erich JAEGER GmbH, Hoechberg, Germany) to determine their maximal oxygen uptake (VO~2max~), HR~max~, maximal peak respiratory minute volume (VE~max~), before and after the completion of a 12-week training period. The device was calibrated in accordance with the manufacturer's instructions. A previously implemented protocol was used to determine VO~2max~ ([@j_hukin-2016-0055_ref_042]). The test began by 5 min continuous pedaling, with a frequency of 60 revolutions per minute (RPM) and a relative load of 1.2 W/kg. After this phase, the workload was systematically increased by 15 watts every minute until voluntary exhaustion. The effort was interrupted when pedaling frequency declined by 10%, that is, when the pedalling frequency fell below 54 RPM. All of the participants reached RER greater than 1.0. The highest values of oxygen uptake, heart rate, minute ventilation and power output maintained for 15 s were considered to be VO~2max~, HR~max~, VE~max~ and P~max~, respectively. The anaerobic threshold (AT) values were obtained using the V-slope method ([@j_hukin-2016-0055_ref_007]). Briefly, after measuring participant's VO~2max~ and VCO~2max~, a plot of changes of VCO~2max~ as a function of VO~2max~ was generated. The point, where the change in the slopes occurred because of increased CO~2~ production connected with lactate accumulation was identified as VO~2~/AT value.

The Wingate anaerobic test {#j_hukin-2016-0055_s_002_s_006}
--------------------------

A 30-s Wingate test on a cycle ergometer (Monark Ergomedic 894 E, Monark, Sweden) was used to assess peak power and total work before and after the completion of the 12-week training period. A relative load corresponding to 7.5% of the subject's body mass was applied ([@j_hukin-2016-0055_ref_012]; [@j_hukin-2016-0055_ref_023]). Before performing the test, the participants completed a 10-min warm-up, including pedaling at a frequency of 60 RPM, with a relative load of 1.2 W/kg and three rapid accelerations between the 7th and 10th minute ([@j_hukin-2016-0055_ref_028]). After the warm-up, the subjects performed stretching and relaxing exercises for 5 min and then started the test ([@j_hukin-2016-0055_ref_004]).

Genetic Analyses {#j_hukin-2016-0055_s_002_s_007}
----------------

The buccal cells donated by the subjects were collected in Resuspension Solution (GenElute Mammalian Genomic DNA Miniprep Kit, Sigma, Germany) with the use of sterile foam-tipped applicators (Puritan, USA). DNA was extracted from the buccal cells using a GenElute Mammalian Genomic DNA Miniprep Kit (Sigma, Germany) according to the manufacturer's protocol. All samples were genotyped in duplicate using an allelic discrimination assay on a StepOne Real-Time Polymerase Chain Reaction (RT-PCR) instrument (Applied Biosystems, USA) as previously described ([@j_hukin-2016-0055_ref_042]).

Statistical Analyses {#j_hukin-2016-0055_s_002_s_008}
--------------------

Allele frequencies were determined by gene counting. To test the influence of the *MTHFR* A1298C polymorphism on training response, 2 × 2 mixed-design ANOVA was used. Additionally, the Kolmogorov-Smirnov test was used to check for data normality, and the post hoc Tukey test was applied when interaction was significant and used to perform pair-wise comparisons. The level of statistical significance was set at *p* \< 0.05.

Results {#j_hukin-2016-0055_s_003}
=======

Genotypes were determined for all 201 DNA samples of participants -- genotyping error was assessed as 0%, while the call rate (the proportion of samples in which genotyping provided unambiguous reading) was 100%.

In order to examine a hypothesis that the *MTHFR* polymorphism modulates aerobic training response, we conducted a mixed 2 x 2 ANOVA with one between-subject (*MTHFR* genotype: CC+AC vs AA) and one within-subject factor (time: before vs after aerobic training) for 20 dependent variables grouped in three categories ([Tables 1](#j_hukin-2016-0055_tab_001){ref-type="table"}-[3](#j_hukin-2016-0055_tab_003){ref-type="table"}). Sixteen significant main effects of performed training were identified: i) body mass and body composition measurements, ii) maximal oxygen uptake variables, as well as, iii) Wingate test variables. Only four variables analyzed did not improve following training: FFM (F~(1,199)~ = 2.72, *p* = 0.100, [Table 1](#j_hukin-2016-0055_tab_001){ref-type="table"}), TBW (F~(1,199)~ = 1.30, *p* = 0.255, [Table 1](#j_hukin-2016-0055_tab_001){ref-type="table"}), VO~2~AT/VO~2max~ (F~(1,199)~ = 1.84, *p* = 0.177, [Table 2](#j_hukin-2016-0055_tab_002){ref-type="table"}) and HR/AT (F~(1,199)~ = 3.00, *p* = 0.083, [Table 2](#j_hukin-2016-0055_tab_002){ref-type="table"}).

###### 

MTHFR genotypes and body mass and body composition variables before and after training (two-way mixed ANOVA)

  Variable                  CC+AC (n = 120)   AA (n = 81)                             Genotype x Training                   
  ------------------------- ----------------- ------------- ------------ ------------ --------------------- --------------- -------------
  BM (kg)                   61.0 ± 6.1        60.4 ± 6.3    59.2 ± 6.8   58.8 ± 6.7   *p* = 0.064           *p* \< 0.0001   *p* = 0.511
  BMI (kg x m-2)            21.8 ± 2.5        21.6 ± 2.5    21.4 ± 2.5   21.3 ± 2.3   *p* = 0.267           *p* \< 0.0001   *p* = 0.357
  BMR (kJ)                  6074 ± 262        6054 ± 271    5999 ± 285   5975 ± 283   *p* = 0.052           *p* \< 0.0001   *p* = 0.569
  Tissue impedance (Ohm)    551 ± 65          544 ± 61      560 ± 51     552 ± 53     *p* = 0.301           *p* = 0.002     *p* = 0.694
  Fat mass percentage (%)   24.7 ± 4.9        23.8 ± 5.0    23.7 ± 5.0   22.8 ± 5.3   *p* = 0.168           *p* \< 0.0001   *p* = 0.972
  Fat mass (kg)             15.3 ± 4.3        14.6 ± 4.4    14.3 ± 4.6   13.7 ± 4.8   *p* = 0.138           *p* \< 0.0001   *p* = 0.971
  FFM (kg)                  45.7 ± 2.4        45.8 ± 2.4    45.0 ± 2.7   45.1 ± 2.7   *p* = 0.049           *p* = 0.100     *p* = 0.989
  TBW (kg)                  33.4 ± 1.7        33.5 ± 1.7    32.9 ± 2.0   33.0 ± 2.0   *p* = 0.041           *p* = 0.255     *p* = 0.734

Values of the variables of both groups before and after training are means (± SD); \* p-value 0.05; BM -- body mass; BMI -- body mass index; BMR -- basal metabolic rate; FFM -- free fat mass; TBW -- total body water

###### 

MTHFR genotypes and maximal oxygen uptake test variables before and after training (two-way mixed ANOVA)

  Variable               CC+AC (n = 120)   AA (n = 81)                               Genotype x Training Before training                   
  ---------------------- ----------------- ------------- ------------- ------------- ------------------------------------- --------------- ---------------
  VO~2max~ (l)           2.03 ± 0.28       2.16 ± 0.32   1.99 ± 0.22   2.04 ± 0.29   *p* =0.033                            *p* \< 0.0001   *p* =0.024
  VO~2max~ (ml/kg/min)   33.5 ± 4.7        35.9 ± 5.3    33.8 ± 3.4    35.0 ± 5.4    *p* =0.633                            *p* \< 0.0001   *p* =0.027
  VO2/AT (ml/kg/min)     25.9 ± 3.9        27.1 ± 3.9    26.1 ± 3.3    26.9 ± 3.7    *p* =0.916                            *p* \< 0.001    *p* =0.416
  VO2AT/VO~2max~ (%)     0.77 ± 0.07       0.76 ± 0.06   0.78 ± 0.07   0.77 ± 0.06   *p* =0.220                            *p* =0.177      *p* =0.236
  HR~max~ (beats/min)    188 ± 8           190 ± 8       191 ± 8       188 ± 7       *p* =0.901                            *p* =0.047      *p* \< 0.0001
  HR/AT (beats/min)      170 ± 7           171 ± 7       172 ± 8       172 ± 7       *p* =0.208                            *p* =0.083      *p* =0.165
  HR~AT~/HR~max~ (%)     0.90 ± 0.02       0.90 ± 0.01   0.90 ± 0.02   0.92 ± 0.01   *p* =0.002                            *p* \< 0.0001   *p* \< 0.0001
  VE~max~ (l/min)        76.5 ± 16.7       81.4 ± 16.7   76.9 ± 13.1   78.6 ± 11.7   *p* =0.535                            *p* =0.001      *p* =0.109
  VE/AT (l/min)          41.7 ± 7.6        44.9 ± 8.8    41.4 ± 8.7    44.2 ± 6.4    *p* = 0.628                           *p* \< 0.0001   *p* = 0.707
  VE~AT~/VE~max~ (%)     0.56 ± 0.08       0.56 ± 0.08   0.54 ± 0.10   0.60 ± 0.09   *p* = 0.996                           *p* = 0.015     *p* = 0.064

Values of the variables of both groups before and after training are means (± SD); VO~2max~ - maximum oxygen uptake; VO~2~/AT - oxygen uptake at the anaerobic threshold; VO~2~AT/VO~2max~ - percentage of VO~2max~at the anaerobic threshold; HR~max~ -- maximum heart rate; HR/AT -- heart rate at anaerobic threshold; HR~AT~/HR~max~ - percentage of HR~max~ at the anaerobic threshold; VE~max~- maximum minute ventilation; VE/AT -- minute ventilation at the anaerobic threshold; VE~AT~/VE~max~ - percentage of VE~max~ at the anaerobic threshold

There was no significant interaction of the genotype with training for body mass and body composition variables ([Table 1](#j_hukin-2016-0055_tab_001){ref-type="table"}.). There were three significant genotype x training interactions for maximal oxygen uptake variables, i.e.: for absolute VO~2max~ (F~(1,199)~ = 4.9, *p* = 0.024) and VO~2max~ per body mass (F~(1,199)~ = 4.93, *p* = 0.027), HR~max~ (F~(1,199)~ = 31.3, *p* \< 0.0001) and HR~AT~/HR~max~ (F~(1,199)~ = 21.1, *p* \< 0.0001) ([Table 2](#j_hukin-2016-0055_tab_002){ref-type="table"}). There was no interaction effect between the genotype and training for Wingate test variables ([Table 3](#j_hukin-2016-0055_tab_003){ref-type="table"}).

###### 

MTHFR genotypes and Wingate test parameters before and after training (two-way mixed ANOVA)

  Variable        CC+AC (n = 120)   AA (n = 81)                               Genotype x Training                   
  --------------- ----------------- ------------- ------------- ------------- --------------------- --------------- -------------
  P~max~ (W)      464 ± 67          467 ± 65      453 ± 67      454 ± 61      *p* = 0.186           *p* = 0.433     *p* = 0.717
  P~max~ (W/kg)   7.62 ± 0.88       7.73 ± 0.74   7.66 ± 0.81   7.74 ± 0.75   *p* = 0.808           *p* = 0.021     *p* = 0.718
  W~tot~ (J/kg)   178 ± 18          186 ± 15      181 ± 18      191 ± 18      *p* = 0.147           *p* \< 0.0001   *p* = 0.311

Values of the variables of both groups before and after training are means (± SD); P~max~ -- maximal power; W~tot~ -- total work output

Discussion {#j_hukin-2016-0055_s_004}
==========

The present study aimed to test whether the A1298C polymorphism in the MTHFR gene had influence on aerobic and anaerobic performance as well as body and mass composition in 201 young Polish women after the completion of a 12-week training program.

We identified 16 significant main effects of performed training on body mass and body composition measurements, maximal oxygen uptake variables, and anaerobic exercise performance variables. However, with reference to interactions between the genotype and training, only significant effects of MTHFR genotypes on VO2max variables were observed (for absolute and relative maximum oxygen uptake, maximum heart rate and percentage of maximum heart rate at the anaerobic threshold).

Our study showed that C allele carriers increased significantly their maximum oxygen uptake after the completion of a 12-week training program when compared to AA homozygotes, regardless of changes in body mass. The lack of significant changes of HRAT/HRmax in the group CC+AC also suggests that the examined group reacted more to the training loads obtaining energy from anaerobic sources which resulted in non-significant changes expressed in percentages.

The AA genotype group obtained the energy needed to perform the same effort from aerobic transformation to a greater extent than the CC+AC genotype group, which caused the anaerobic threshold shift for the HR in the direction of higher values, while reducing the maximum heart rate. A significant increase in VO2max, while reducing the maximum heart rate and an increase of HRAT/HRmax is a common physiological response to loads such as aerobic energy transformation carried out at and below the anaerobic threshold. Furthermore, analyzing the obtained results it can be concluded that both the C allele carriers and AA group reacted properly in terms of exercise physiology to the prescribed training load, improving the results aiming at adaptation to efforts of aerobic exercise, therefore increasing cardiovascular capacity.

As it has been previously stated, the MTHFR gene encodes 5,10-methylenetetrahydrofolate reductase, one of the crucial enzymes in the single-carbon fragments metabolism i.e. conversion of homocysteine to methionine. The C677T TT as well as A1298C CC homozygotes have been shown to have a decreased enzymatic activity as well as significantly elevated plasma homocysteine levels ([@j_hukin-2016-0055_ref_009], [@j_hukin-2016-0055_ref_008]; [@j_hukin-2016-0055_ref_016]). Other studies that have analyzed 5,10-methylenetetrahydrofolate reductase activity found that individuals analyzed for both C677T and A1298C polymorphisms had lowered enzyme activity, but only when 677 CT and 1298 AC heterozygous genotypes occurred ([@j_hukin-2016-0055_ref_040]; [@j_hukin-2016-0055_ref_038]). There are strong indications that MTHFR is involved in DNA methylation because it is a critical enzyme in the metabolism of homocysteine and methionine - the latter is a universal donor of methyl groups ([@j_hukin-2016-0055_ref_031]). Indeed, it has been shown that both MTHFR C677T and A1298C polymorphic sites showed effects on DNA methylation status. With respect to the A1298C variant, it has been observed that the 1298CC MTHFR genotype is associated with DNA hypomethylation status ([@j_hukin-2016-0055_ref_015]; [@j_hukin-2016-0055_ref_039]). Investigation by [@j_hukin-2016-0055_ref_037] aimed to analyze elite athletes for 7 polymorphic variants in 5 genes (including MTHFR A1298C variant) involved in the one-carbon metabolism as well as to check whether DNA hypomethylation would increase the expression of muscle specific genes. The study revealed that elite athletes possessed DNA polymorphisms of DNA methylation cycle enzymes that might predispose them to quicker DNA hypomethylation and, in consequence, increased speed of entry into S phase, and then DNA synthesis. With respect to the MTHFR A1298C gene variant, the over-representation of the C allele associated with decreased DNA methylation was found in athletes. Therefore, it was suggested that the exercise-induced demethylation in athletes was easier and more rapid, thereby resulting in increased gene expression of factors that determined proliferation and differentiation of myoblasts, what in consequence promoted muscle growth ([@j_hukin-2016-0055_ref_037]).

Our study revealed that C allel carriers were more prone to increase their maximum oxygen uptake after completion of the 12-week training program than the AA homozygotes. In view of the above mentioned facts, it might be speculated that the CC+AC group benefited from carrying the C allele of the MTHFR A1298C polymorphism probably due to quicker DNA hypomethylation and a higher rate of DNA synthesis, what in consequence increased expression of critical genes involved in proliferation and differentiation of myoblasts as well as mitochondrial biogenesis.

Several studies have reported the role of DNA methylation in a tissue-specific gene expression during development ([@j_hukin-2016-0055_ref_017]; [@j_hukin-2016-0055_ref_032]). It has also been demonstrated that hypomethylation modulates muscle differentiation and growth ([@j_hukin-2016-0055_ref_030]). Particularly, myogenic transcription factors are known to be involved in the myogenic differentiation and in the induction of muscle-specific genes expression. In vitro studies in the immortalized cell line derived from satellite cells have shown that hypomethylation increases the expression of myogenic regulatory factors during the early (Myf-5 and MyoD), intermediate (Myf-6), and late phase (MHC) of myogenesis. Both Myf-5 and MyoD are required for myogenic determination, as well as Myf-6 which plays a role in terminal differentiation inducing an increment in the MHC muscle-specific gene expression ([@j_hukin-2016-0055_ref_037]). Regular endurance aerobic exercise influences mitochondrial biogenesis by increasing mitochondrial content and volume which in consequence improves oxidative capacity ([@j_hukin-2016-0055_ref_020]). It has been shown that mitochondrial biogenesis is regulated by many transcription factors and their co-activators ([@j_hukin-2016-0055_ref_010]). Mitochondrial biogenesis is regulated by energy sensors such as protein kinase A (PKA), cAMP response element-binding protein (CREB), 5′ adenosine monophosphate-activated protein kinase (AMPK) and sirutin (SIRT1) that activate peroxisome proliferator-activated receptor γ coactivator 1α (PGC1α). The latter induces the downstream targets (i.e. nuclear respiratory factors NRF1, NRF2 and Tfam) what results in upregulation of mitochondrial biogenesis and activity ([@j_hukin-2016-0055_ref_027]). Epigenetic studies have suggested that the expression of PGC1α may be controlled at the level of DNA methylation of PPARGC1A promoter and exercise changes DNA methylation of the promoter of PPARGC1A to favor gene expression responsible for mitochondrial biogenesis and function ([@j_hukin-2016-0055_ref_018]; [@j_hukin-2016-0055_ref_033]). Recently, the study by [@j_hukin-2016-0055_ref_005] reported that upregulation of PGC-1α was associated with dynamic change in DNA methylation in skeletal muscle.

The present study has several limitations that should be mentioned. Obtained results were received during genetic association studies and need to be interpreted with caution as they could be influenced by many factors. We observed that C-allel carries were better responders to the 12-week aerobic training program in terms of higher maximum oxygen uptake. However, it is unclear whether and to what extent the effect was due to changes in DNA methylation, because in this study we did not directly measure the methylation status of the participants. As far as we know, DNA methylation is a complex process that needs a variety of accessory proteins and modifying enzymes in establishing and maintaining these chemical modifications to DNA ([@j_hukin-2016-0055_ref_041]). Therefore, other genes and their polymorphic variants of proteins that are directly engaged in DNA methylation such as DNA methyltransferases (DNMTs), ten-eleven translocation (TET) proteins as well as the methionine synthase (MS) methionine synthase reductase (MSR), cystathionine-synthase (CBS) and betaine-homocysteine methyltransferase (BHMT) are of potential interest ([@j_hukin-2016-0055_ref_024]; [@j_hukin-2016-0055_ref_037]). It might be suspected that due to a polygenic character of VO2max, only a small part of the total variance of this trait could be explained by the MTHFR A1298C polymorphism. Moreover, methylation marks can be modified not only by exercise, but also other environmental factors such as exposure to toxic chemicals (i.e. heavy metals, antiandrogenic toxins) and nutrition (folic acid suplementation or restriction) ([@j_hukin-2016-0055_ref_006]; [@j_hukin-2016-0055_ref_013]). Finally, DNA methylation does not solely control the exercise-induced gene expression, as the complex transduction network with numerous signaling pathways is regulated at different molecular levels ([@j_hukin-2016-0055_ref_005]; [@j_hukin-2016-0055_ref_010]).

In conclusion, it was observed that, as a result of training, significantly greater improvement in VO2max was gained by the CC+AC group compared to the AA genotype group. The results support the hypothesis that individual differences in trainability are at least in part determined by the genetic component and MTHFR A1298C seems to be one of the many polymorphisms involved.

The study was supported by the National Science Centre (grant no. 2012/07/B/NZ7/01155).
